SUPNCongressional Stock Trades
Supernus Pharmaceuticals, Inc.
Pharmaceutical Preparations
Congressional stock trades in Supernus Pharmaceuticals, Inc. (SUPN) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
3
Politicians Trading
1
Last Traded
Dec 11, 2025
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr.D | Jan 12, 2026 | Dec 11, 2025 | Buy | $1,001 - $15,000 | -9.70% |
| Gilbert Ray Cisneros, Jr.D | Apr 7, 2025 | Mar 24, 2025 | Buy | $1,001 - $15,000 | +28.44% |
Price History
About Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.